Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S Eckstein
The New Provisional WHO Entity ‘RUNX1 Mutated AML’ Shows Specific Genetics but No Prognostic Influence of Dysplasia
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Related publications
Prognostic Models Turn the Heat(IT)up on FLT3ITD-mutated AML
Clinical Cancer Research
Cancer Research
Oncology
NPM1 Mutant Variant Allele Frequency Correlates With Leukemia Burden but Does Not Provide Prognostic Information in NPM1-mutated AML
American Journal of Hematology
Hematology
Molecular Genetics of AML
Best Practice and Research in Clinical Haematology
Oncology
Clinical Biochemistry
Recurrent Somatic JAK-STAT Pathway Variants Within a RUNX1-mutated Pedigree
European Journal of Human Genetics
Genetics
A Selective FLT3 Inhibitor Shows Clinical Efficacy in AML
Cancer Discovery
Oncology
Who Owns Plant Genetics?
Nature Genetics
Genetics
A New Time-Dependent Approach for Assessment of the Impact of Invasive Aspergillosis Shows Effect on Short- But Not on Long-Term Survival of Patients With AML or High-Risk MDS
Bone Marrow Transplantation
Transplantation
Hematology
Situs Inversus Totalis, Renal and Pancreatic Dysplasia, and Cysts as an Autosomal Recessive New Entity?
Genetics in Medicine
Medicine
Genetics
Inhibition of FLT3 Expression by Green Tea Catechins in FLT3 Mutated-Aml Cells
PLoS ONE
Multidisciplinary
